
Sign up to save your podcasts
Or
Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.
5
77 ratings
Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.
1,040 Listeners
31 Listeners
274 Listeners
309 Listeners
331 Listeners
394 Listeners
122 Listeners
318 Listeners
198 Listeners
84 Listeners
88 Listeners
428 Listeners
147 Listeners
18 Listeners
84 Listeners